Lyell Immunopharma Inc (LYEL) — Capital Reinvestment Ratio
Lyell Immunopharma Inc (LYEL) has a Capital Reinvestment Ratio of 0.41x as of December 2019, meaning it reinvests 0% of its operating cash flow ($39.47 Million) in capital expenditures ($16.05 Million). See Lyell Immunopharma Inc (LYEL) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lyell Immunopharma Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Lyell Immunopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Check cash flow reinvestment rate of Lyell Immunopharma Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Lyell Immunopharma Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Lyell Immunopharma Inc from 2019 to 2019. For live market cap and broader valuation context, see market cap of Lyell Immunopharma Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.41x | $39.47 Million | $16.05 Million | — |